share_log

Prestige Consumer Healthcare (NYSE:PBH) Price Target Cut to $63.00 by Analysts at Oppenheimer

Prestige Consumer Healthcare (NYSE:PBH) Price Target Cut to $63.00 by Analysts at Oppenheimer

威望消費者保健公司(NYSE：PBH)目標價被奧本海默分析師下調至63.00美元
Defense World ·  2022/09/30 05:22

Prestige Consumer Healthcare (NYSE:PBH – Get Rating) had its target price cut by Oppenheimer to $63.00 in a research note published on Thursday, Stock Target Advisor reports.

據Stock Target Advisor報道，在週四發佈的一份研究報告中，威望消費者醫療保健公司(NYSE：PBH-GET評級)的目標價被奧本海默下調至63.00美元。

Separately, DA Davidson reaffirmed a neutral rating on shares of Prestige Consumer Healthcare in a report on Tuesday, August 9th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of Moderate Buy and a consensus target price of $80.50.

另外，DA Davidson在8月9日星期二的一份報告中重申了對Prestige Consumer Healthcare股票的中性評級。兩名投資分析師對該股的評級為持有，三名分析師對該公司股票的評級為買入。根據MarketBeat.com的數據，該股的平均評級為中等買入，共識目標價為80.50美元。

Get
到達
Prestige Consumer Healthcare
威望消費者醫療保健
alerts:
警報：

Prestige Consumer Healthcare Stock Up 0.4 %

威望消費者醫療保健類股上漲0.4%

PBH opened at $50.17 on Thursday. The company has a quick ratio of 1.23, a current ratio of 2.09 and a debt-to-equity ratio of 0.93. The firm has a 50 day moving average price of $54.61 and a 200-day moving average price of $55.26. Prestige Consumer Healthcare has a twelve month low of $48.51 and a twelve month high of $63.83. The stock has a market capitalization of $2.50 billion, a price-to-earnings ratio of 12.57, a PEG ratio of 1.45 and a beta of 0.55.

PBH週四開盤報50.17美元。該公司的速動比率為1.23，流動比率為2.09，債務權益比率為0.93。該公司的50日移動均線價格為54.61美元，200日移動均線價格為55.26美元。威望消費者醫療保健公司的12個月低點為48.51美元，12個月高位為63.83美元。該股市值為25億美元，市盈率為12.57倍，聚乙二醇率為1.45倍，貝塔係數為0.55。

Institutional Trading of Prestige Consumer Healthcare

威望消費者醫療保健的機構交易

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. M&G Investment Management Ltd. boosted its position in shares of Prestige Consumer Healthcare by 5.2% in the second quarter. M&G Investment Management Ltd. now owns 29,077 shares of the company's stock worth $1,716,000 after purchasing an additional 1,446 shares during the period. Summit Global Investments boosted its position in shares of Prestige Consumer Healthcare by 87.3% in the second quarter. Summit Global Investments now owns 48,428 shares of the company's stock worth $2,848,000 after purchasing an additional 22,566 shares during the period. Captrust Financial Advisors boosted its position in shares of Prestige Consumer Healthcare by 9.1% in the second quarter. Captrust Financial Advisors now owns 3,011 shares of the company's stock worth $177,000 after purchasing an additional 252 shares during the period. Legal & General Group Plc boosted its position in shares of Prestige Consumer Healthcare by 1.4% in the second quarter. Legal & General Group Plc now owns 144,276 shares of the company's stock worth $8,484,000 after purchasing an additional 1,926 shares during the period. Finally, Walleye Capital LLC boosted its position in shares of Prestige Consumer Healthcare by 255.2% in the second quarter. Walleye Capital LLC now owns 28,156 shares of the company's stock worth $1,656,000 after purchasing an additional 20,230 shares during the period. 99.37% of the stock is owned by hedge funds and other institutional investors.
對衝基金和其他機構投資者最近增持或減持了該業務的股份。M&G投資管理有限公司在第二季度將其在Prestige Consumer Healthcare股票的持倉增加了5.2%。M&G投資管理有限公司目前持有29,077股該公司股票，價值1,716,000美元，在此期間又購買了1,446股。Summit Global Investments在第二季度將其在Prestige Consumer Healthcare的股票頭寸提高了87.3%。Summit Global Investments在此期間又購買了22,566股，現在擁有48,428股該公司股票，價值2,848,000美元。CapTrust Financial Advisors在第二季度將其在Prestige Consumer Healthcare股票的持倉增加了9.1%。CapTrust Financial Advisors在此期間額外購買了252股，現在擁有3,011股該公司股票，價值17.7萬美元。Legal&General Group Plc在第二季度將其在Prestige Consumer Healthcare的股票頭寸增加了1.4%。Legal&General Group Plc現在擁有144,276股該公司股票，價值8,484,000美元，在此期間又購買了1,926股。最後，Walleye Capital LLC在第二季度將其在Prestige Consumer Healthcare的股票頭寸提高了255.2%。Walleye Capital LLC現在擁有28,156股該公司的股票，價值1,656,000美元，在此期間又購買了20,230股。99.37%的股票由對衝基金和其他機構投資者持有。

About Prestige Consumer Healthcare

關於Prestige Consumer Healthcare

(Get Rating)

(獲取評級)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

威望消費者保健公司及其子公司在美國和國際上開發、製造、營銷、分銷和銷售非處方藥(OTC)健康和個人護理產品。該公司在北美OTC Healthcare和國際OTC Healthcare兩個部門運營。

Recommended Stories

推薦故事

  • Get a free copy of the StockNews.com research report on Prestige Consumer Healthcare (PBH)
  • Humana Proves Vertically Integrated Healthcare Works
  • This Small-Cap Healthcare Name Is Outperforming Its Index
  • 2 Casino Stocks Worth Taking a Look At
  • What Cintas Can Teach Investors About This Bear Market?
  • Blackberry Stock Declines As Results Come In Lukewarm Once Again
  • 免費獲取StockNews.com關於Prestige Consumer Healthcare(PBH)的研究報告
  • Humana證明垂直整合的醫療保健工作
  • 這家小盤股醫療保健公司的表現好於其指數
  • 值得一看的2只賭場股票
  • 關於這個熊市，Cintas能教給投資者什麼？
  • 黑莓股價下跌，業績再次不温不火

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

獲得《尊貴消費者保健日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Prestige Consumer Healthcare和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論